An inductive learning-based method for predicting drug-gene interactions using a multi-relational drug-disease-gene graph.
10.1016/j.jpha.2025.101347
- Author:
Jian HE
1
;
Yanling WU
1
;
Linxi YUAN
1
;
Jiangguo QIU
1
;
Menglong LI
1
;
Xuemei PU
1
;
Yanzhi GUO
1
Author Information
1. College of Chemistry, Sichuan University, Chengdu, 610064, China.
- Publication Type:Journal Article
- Keywords:
Drug-gene interactions;
Graph embedding;
Inductive learning;
Machine learning;
Multi-relational drug-disease-gene graph;
Node attributes
- From:
Journal of Pharmaceutical Analysis
2025;15(8):101347-101347
- CountryChina
- Language:English
-
Abstract:
Computational analysis can accurately detect drug-gene interactions (DGIs) cost-effectively. However, transductive learning models are the hotspot to reveal the promising performance for unknown DGIs (both drugs and genes are present in the training model), without special attention to the unseen DGIs (both drugs and genes are absent in the training model). In view of this, this study, for the first time, proposed an inductive learning-based model for the precise identification of unseen DGIs. In our study, by integrating disease nodes to avoid data sparsity, a multi-relational drug-disease-gene (DDG) graph was constructed to achieve effective fusion of data on DDG intro-relationships and inter-actions. Following the extraction of graph features by utilizing graph embedding algorithms, our next step was the retrieval of the attributes of individual gene and drug nodes. In this way, a hybrid feature characterization was represented by integrating graph features and node attributes. Machine learning (ML) models were built, enabling the fulfillment of transductive predictions of unknown DGIs. To realize inductive learning, this study generated an innovative idea of transforming known node vectors derived from the DDG graph into representations of unseen nodes using node similarities as weights, enabling inductive predictions for the unseen DGIs. Consequently, the final model was superior to existing models, with significant improvement in predicting both external unknown and unseen DGIs. The practical feasibility of our model was further confirmed through case study and molecular docking. In summary, this study establishes an efficient data-driven approach through the proposed modeling, suggesting its value as a promising tool for accelerating drug discovery and repurposing.
